Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Diabetes, Obesity & Metabolism|April 29, 2026
High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology ClinicsSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, et al.American Journal of Physiology. Endocrinology and Metabolism|January 28, 2016
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activityRainey E Patterson, Srilaxmi Kalavalapalli, Caroline M Williams, et al.Journal of Hepatology|January 17, 2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLDDiana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.Obesity (Silver Spring, Md.)|September 24, 2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screenAnu Sharma, Eddison Godina Leiva, Srilaxmi Kalavalapalli, et al.Diabetes Care|December 23, 2020
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic ScreeningRomina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.The Journal of Clinical Endocrinology and Metabolism|November 15, 2022
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLDSrilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, et al.Nature Communications|February 17, 2017
Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistanceJoonseok Cho, Yujian Zhang, Shi-Young Park, et al.Nature Communications|July 16, 2019
Corrigendum: Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistanceJoonseok Cho, Yujian Zhang, Shi-Young Park, et al.Metabolism: Clinical and Experimental|June 21, 2020
Targeting pheochromocytoma/paraganglioma with polyamine inhibitorsSudhir Kumar Rai, Fernando Bril, Heather M Hatch, et al.Pageof 3